Report ID : 1290550 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Animal-Derived Chymosin Market is categorized based on Type (Microbial Chymosin, Animal Chymosin) and Application (Cheese Production, Pharmaceuticals, Beverages, Food Additives, Others) and Form (Liquid, Powder) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The market size of Animal-Derived Chymosin Market, valued at USD 1.5 billion in 2023, is projected to reach USD 2.8 billion by 2033, expanding at a CAGR of 6.5% between 2024 and 2033. The report comprises various segments and analyzes significant trends and factors influencing market growth.
The Animal-Derived Chymosin Market is changing noticeably, thanks to high demand for good quality dairy products and the growing appeal of traditional cheese making methods. One of the crucial components in cheese manufacturing is chymosin, which is an enzyme extracted from the stomachs of herbivorous animals. As the directed eating trend continues, where people become increasingly conscious about the source and credibility of their food, the scope of animal derived chymosin is likely to broaden, thus, creating an opportunity for producers and suppliers.
Several recent events like, proliferation of biotechnology and shift towards more artisanal food production have sculpted the structure of the market. The enzyme industry faces competition from plant-based and microbial alternatives. However, the functional advantages and specialized attributes of animal-derived chymosin is still attractive to many cheese manufactures that attempt to achieve authentic taste and texture. Stakeholders are forced to mobilize themselves in this constantly transforming setting to satisfy new market demands and stringent control norms. Not only does this constantly changing world produce new obstacles, but new horizons as well.
ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2023-2033 |
BASE YEAR | 2023 |
FORECAST PERIOD | 2024-2033 |
HISTORICAL PERIOD | 2023-2024 |
UNIT | VALUE (USD BILLION) |
KEY COMPANIES PROFILED | Chr. Hansen Holding A/S, Dupont de Nemours Inc., DSM Nutritional Products AG, Novozymes A/S, SternEnzym GmbH & Co. KG, Enzyme Development Corporation, Amano Enzyme Inc., SAB Biotherapeutics Inc., Kraft Heinz Company, Givaudan SA, Renco Corporation |
SEGMENTS COVERED |
By Type - Microbial Chymosin, Animal Chymosin By Application - Cheese Production, Pharmaceuticals, Beverages, Food Additives, Others By Form - Liquid, Powder By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
The Animal-Derived Chymosin Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
Verified Industry Insights offers one of the following report customization options to our respectable clients :
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved